Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy

ChemMedChem. 2008 Sep;3(9):1311-5. doi: 10.1002/cmdc.200800091.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Aptamers, Nucleotide / chemistry*
  • Aptamers, Nucleotide / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Drug Delivery Systems / methods
  • Drug Design
  • Drug Screening Assays, Antitumor
  • Ferrosoferric Oxide / chemistry*
  • Ferrosoferric Oxide / pharmacology
  • Humans
  • Magnetics*
  • Male
  • Nanoparticles / chemistry*
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / drug therapy*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Aptamers, Nucleotide
  • Ferrosoferric Oxide